INTRODUCTION
Within current clinical practice, the most common primary liver malignancy is Hepatocellular carcinoma (HCC) [1] . A combination of intrinsic factors (aberrant epigenetic alterations) and extrinsic risk factors, produces dysregulated cell signaling pathways that result in tumorogenesis within the primary liver parenchyma cell lines, the hepatocytes [2] . The global incidence of HCC is increasing [3] . A SEER-Medicare database review highlighted the significant socio-economic burden of HCC on today's society [4] . In light of the disease's prevalence and clinical outcomes, research has been focused on enhancing our understanding of the pathophysiology of the disease and developing novel treatment strategies. Increasing our understanding of HCC will govern and influence current clinical practice, thus ensuring that appropriate management algorithms are created and surveillance screening protocols can be implemented for high-risk patient cohorts.
One method of identifying published research of the most intellectual influence is through creating a citation rank list [5] . After a manuscript is published, if it is referenced by another peer-reviewed article, a citation is generated. It is proposed that original research with the greatest influence would subsequently be cited several times. Citation analysis enables the ranking of published research based upon the total number of citations each individual article has received. This method can be implemented to create a list of journals that have had a significant impact on their respected specialty [5] .
Several surgical specialties have performed a citation rank analysis in an attempt to identify the most influential papers from within their own respective field [6] [7] [8] . No study has assessed for the most influential HCC manuscripts. Such an analysis would facilitate our understanding of how our knowledge of HCC has developed and subsequently impacted on clinical management. The aim of this study is to identify the studies of greatest clinical influence that has augmented our knowledge regarding HCC.
MATERIALS AND METHODS
A search through the online Thomson Reuters Web of Science citation indexing database was performed. Predefined search terminologies were incorporated into the search. The search strategy included "hepatocellular carcinoma" and "HCC". Boolean operators were included in order to optimise the accuracy of the search and to facilitate large data capture. Two independent researchers conducted the search simultaneously in order to ensure that the search was accurate and that all relevant manuscripts were identified and included. The search result from the Thomson Reuters Web of Science database was subsequently filtered to include full manuscripts of English language only. The results were further sorted by number of citations as described previously. The exclusion criteria for this study included all non-English manuscripts and manuscripts that did not specifically focus on HCC related research. The 100 most cited HCC related articles were identified and documented. Each article was reviewed and data was obtained for the following variables: topic, author list, year of publication, country of origin and publishing journal. Every included journal had its individual and five year impact factor recorded. Due to the nature and methodology used for bibliometric analyses, this type of study is susceptible to bias. One such limitation is that historical manuscripts may accrue a higher number of citations over time despite missing the influence of newer 'higher impact' publications. In an attempt to overcome such a limitation, the citation rate index was calculated by dividing the number of citations by the number of years since publication.
RESULTS
A total of 39,518 full length, English language papers were identified following a search through the Thomson Reuters Web of Science database. Table 1 illustrates the 100 most cited HCC articles [68] .
The articles were published across 21 journals ( Table  2 ). The range of articles published per journal was 1-20. Hepatology published the most articles (n=20), resulting in a total citation rate of 20,533. The Lancet had the overall highest citation rate of 39,219, despite only publishing 9 articles. The journal with the highest impact factor and five-year impact factor was the New England Journal of Medicine (72.406 and 64.201 respectively).
A wide geographical distribution of the articles within the 100 most cited HCC articles was noted (Figure 1 ). The United Stated of America was the country that produced the highest number of papers that featured within the 100 most cited HCC manuscripts (n=32), followed by Japan (n=19) and Spain and Italy (n=13, respectively). The University of Tokyo (Japan) had the greatest number of published manuscripts (n= 8) followed by Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) institute (Spain) (n=7) ( Table 3) . Two authors (Bruix J, Llovet J) had 6 first author publications within the 100 most cited articles and one author had five first name publications (Livraghi, T).
The citation rate index is defined in the literature through a specific formula; the number of citations an article has received divided by the number of years since its original publication [8, 109] (Table  4 ). The citation rate index was calculated for all articles, the highest citation rate index for the top 10 [12, 20] .
Each manuscript was reviewed in order to identify its principle subject matter (Table 5 ). Of the 100 most 
DISCUSSION
Advances and expansion of novel treatment strategies (ranging from transplantation to ablation), the creation of prognostication systems and a further understanding on the impact of genetics on disease pathophysiology and aetiological risk factors represent 76% of the manuscripts within the 100 most cited HCC articles. This acquired knowledge influences current clinical practice and leads evidence based medicine. Identification of risk factors (notably the hepatitis viruses) has permitted the creation of surveillance and screening protocols for high-risk patient cohorts.
This bibliometric analysis included a range of different topics. Management of HCC was the main emphasis of 31 of the 100 most cited articles. Several different treatment strategies have been described for HCC. Surgical resection of HCC has historically been described as the main curative treatment option [87] . However, manuscripts evaluating the surgical management of HCC only accounted for 6 articles, thus underrepresented in this bibliometric analysis. Not all patients with HCC are candidates for surgical intervention. This may be due to tumor factors (large volume disease, bi-lobar disease, vascular involvement or inadequate liver remnant), patient factors (pre-existing comorbidities) or compromised liver function (secondary to liver cirrhosis) [110] . Historically, these patients were offered palliative treatment alone, however newer management strategies, such as radiofrequency ablation (RFA) can be used as a treatment options for this cohort of patients where surgery is contraindicated. It is not surprising that ablation was the most commonly described treatment strategy in this bibliometric analysis (11 articles). Both RFA and Microwave ablation (MWA) have been described within this bibliometric analysis. For patients with HCC and significant cirrhosis, pharmaceutical drug based manipulation is a key aspect of palliative therapy [111, 112] , in particular the tyrosine kinase inhibitor, Sorafenib [43] . For any scientific researcher or clinician treating cancer, the clinical emphasis is achieving a cure whenever possible. The harsh reality is that this is not always possible, thus reinforcing the need to develop adjuvant treatments and palliative management strategies. As with other Upper Gastrointestinal cancers, notably Oesophageal and Gastric cancer, the five year survival is poor. Bibliometric analyses reviewing Oesophageal and Gastric cancer have also highlighted that chemotherapy (in the context of neo/adjuvant or palliative chemotherapy) is frequently discussed topic in the 100 most cited articles (n=34 and n=10 respectively) [8, 113] . This demonstrates the importance of multimodal therapeutic approaches to treating cancer.
Our understanding of the natural history of HCC has significantly increased over the last decade. The identification of risk factors for HCC allows further risk stratification of patients. HCC aetiology represented 15 articles of the 100 most cited manuscripts. Historical risk factors for HCC development include chronic hepatitis, cirrhosis and Aflatoxin exposure [114] . However, with global rates of obesity rising, incidence rates of HCC are increasing as a consequence to the metabolic syndrome and subsequent non alcoholic steato-hepatitis (NASH) [114] 7. A bibliometric analysis is a dynamic and fluid process; over time newly acquired information will be integrated and dispersed throughout the subject field with reflexive changes in the 100 most cited articles. An argument could be made that a bibliometric analysis will need to be repeated every 5-10 years to identify avenues of important scientific traction. In the context of aetiology of HCC, it is hypothesized that repeating this bibliometric analysis in a decade would reflect NASH as a common causative mechanism which will likely have a greater representation in the 100 manuscripts [115] .
Published manuscripts that significantly impact clinical practice are frequently read, analysed and subsequently cited. The total number of citations forms the basis of the impact factor. The most influential journals can be identified by using the impact factor (IF). The IF is defined as the average number of citations a published manuscript within a journal receives, in a specific time period. Within this bibliometric analysis, the journals with the highest IF were the New England Journal of Medicine (IF of 72.41), the Lancet (IF of 47.83) and the Journal of the American Medical Association (IF of 44.41). The median IF for this bibliometric analysis was 18.39. This is significantly higher than the median IF seen in bibliometric analyses on gastric and oesohpageal cancer (9.28 and 15.69 respectively) [8, 115] . Possible reasons for this include the global burden of HCC on healthcare systems and the novelty of the manuscripts findings, representing break through in research within their respective field of specialization. Due to the geographical distribution and global prevalence of HCC, it is likely that key ground breaking concepts in both diagnosis and management of the disease are more likely to be accepted in high IF journals in order to obtain a wider audience and to have a greater impact on clinical practice. Journals with a very high IF (IF > 30) included 32% of all published manuscripts within this bibliometric analysis. Only 2 articles were published in journals with an IF less than 5. There are inherent limitations associated with bibliometic studies of this kind. These include institutional bias, powerful person bias and English language bias. Due to the geographical distribution of HCC (Sub-Saharan Africa and South East Asia), there is an argument that large studies originated from these countries may have published within their own language, thus may not appear in our findings. However, it is likely that studies with significant findings would have been submitted to English language journals in order to achieve maximum global exposure and publicity. Another limitation of this study is the bibliometric analysis of first and last authors only. Moreover, only the institution of the first author was noted. It is likely that authors will have contributed to other highly cited studies, and this method of author analysis may underestimate the author contribution in general. Historical manuscripts accrue citations over time, however the calculation and use of the citation rate index addresses this limitation.
CONCLUSION
This bibliometric analysis identified the 100 most cited HCC manuscripts within the current literature. The two most cited topics within this bibliometric analysis were aetiological risk factors and therapeutic treatment options for HCC. The management algorithm for patients with HCC has significantly changed over the last decade. Treatment strategies are now available for a cohort of patients who were once considered palliative. This advancement reflects a greater understanding of HCC disease biology and has impacted on patient care. Over a third of the articles in this bibliometric analysis were published in very high impact factor journals (Impact factor > 30), thus representing the novelty and the global importance of their findings. The study serves as a reference point for potential future HCC research themes.
